Skanska to build AstraZeneca site

By Neill Barston18 February 2015

A computer generated image of the new AstraZeneca science facilities in Cambridge

A computer generated image of the new AstraZeneca science facilities in Cambridge

Skanska has gained an SEK3.7 billion (€388 million) construction contract for a research and development centre for the UK-based AstraZeneca science group.

Designed by Herzog & de Meuron, the new facility in Cambridge, which will also serve as corporate headquarters, will be built on the Cambridge Biomedical Campus.

The scheme will become the company’s largest centre for oncology research, offering facilities for 2,000 employees. Work has now started on the project, which is due to be completed in 2017.

Its development follows Skanska’s latest annual results, which showed year-on-year growth to SEK145.02 billion (€15.05 billion).

Latest News
Watch D&Ri Virtual Conference on Safety and Sustainability
Speakers from Liberty Industrial, Despe, Independence Demolition and Keltbray consider the big issues of demolition site safety and sustainability and how these will impact the industry in the future
Long-term tool rental offered by Kiloutou
600 Milwaukee tools will be avaiable for rent under the initiative
Infortar and Alexa to build LNG terminal
Construction of Paldiski LNG terminal in Estonia will not get financial government support